Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AVIENT CORPAVNT · Entity 4061 | Director | September 30, 2026 | October 02, 2026 |
| Anika Therapeutics, Inc.ANIK · Entity 6005 | Director | June 20, 2025 | June 24, 2025 |
| MASIMO CORPMASI · Entity 39014 | Director | August 11, 2025 | August 12, 2025 |
| Medtronic plcMDT · Entity 2888 | Director | April 27, 2026 | April 29, 2026 |
| STRYKER CORPSYK · Entity 369 | VP and CFO | February 11, 2015 | February 12, 2015 |
| Telix Pharmaceuticals LtdTLX · Entity 4101 | Director | May 11, 2026 | May 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AVIENT CORP
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,132 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 958 · Balance 28,132 |
| Common StockSEC Table I · non-derivative | IndirectDeferred Comp Plan | 44,462.326 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 44,462.326 F1: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors.
Anika Therapeutics, Inc.
Report date June 20, 2025 · Filed June 24, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,403 |
Reported balance
After 2025-06-20 transaction · row 1
1 source rowRow 1 · 2025-06-20 · Grant · Acquired 14,164 · Balance 20,403 F1: These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026. |
| Common StockSEC Table I · non-derivative | IndirectRevocable Trust | 2,700 |
Reported balance
Holding disclosure · report date 2025-06-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,700 F2: Consists of shares transferred by Mr. Jellison to the Amended and Restated William R. Jellison Trust dated July 3, 2018, of which Mr. Jellison is a beneficiary and trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026.
F2: Consists of shares transferred by Mr. Jellison to the Amended and Restated William R. Jellison Trust dated July 3, 2018, of which Mr. Jellison is a beneficiary and trustee.
MASIMO CORP
Report date August 11, 2025 · Filed August 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,790 |
Reported balance
After 2025-08-11 transaction · row 1
1 source rowRow 1 · 2025-08-11 · Purchase · Acquired 3,000 · Balance 4,790 F1: The price reported in Column 4 represents the weighted average price per share of open market purchase transactions. The actual purchase prices ranged from a low of $145.84 per share to a high of $146.00 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 represents the weighted average price per share of open market purchase transactions. The actual purchase prices ranged from a low of $145.84 per share to a high of $146.00 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Medtronic plc
Report date April 27, 2026 · Filed April 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 6,444 |
Reported balance
After 2026-04-27 transaction · row 1
1 source rowRow 1 · 2026-04-27 · Grant · Acquired 1,444 · Balance 6,444 F1: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units that vest on the one-year anniversary of the award date.
STRYKER CORP
Report date February 11, 2015 · Filed February 12, 2015
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option granted 02/11/2015 (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $93.06 · Expires 2025-02-10 | Direct | 26,865 |
Reported balance
After 2015-02-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2015-02-11 · Grant · Acquired 26,865 · Balance 26,865 F1: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant.
Telix Pharmaceuticals Ltd
Report date May 11, 2026 · Filed May 18, 2026
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2019 Filed Apr 2, 2019 19:59 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,023 | $29.33 | $29,999.48 |
DisclosureSEC source: 0001127602-19-014091 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 20,702 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 21:24 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-000688 · form4.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 19,556 Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 21:24 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,061 | $28.31 | $30,036.91 |
DisclosureSEC source: 0001127602-19-000688 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 18,407 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2018 Filed Oct 1, 2018 21:05 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 745 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-028796 · form4.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 17,281 Read SEC document |
| September 30, 2018 Filed Oct 1, 2018 21:05 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 688 | $43.60 | $29,993.36 |
DisclosureSEC source: 0001127602-18-028796 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 16,536 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2018 Filed Jul 2, 2018 20:45 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 660 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-022279 · form4.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 15,792 Read SEC document |
| June 30, 2018 Filed Jul 2, 2018 20:45 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 601 | $43.54 | $26,167.54 |
DisclosureSEC source: 0001127602-18-022279 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 15,132 F1 · balance_after: Includes 53 shares acquired on April 5, 2018 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 21:07 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 677 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-013780 · form4.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 14,478 Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 21:07 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 559 | $42.48 | $23,746.32 |
DisclosureSEC source: 0001127602-18-013780 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 13,801 F1 · balance_after: Includes 45 shares acquired on January 10, 2018 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2017 Filed Jan 2, 2018 21:38 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 656 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-000142 · form4.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 13,197 Read SEC document |
| December 31, 2017 Filed Jan 2, 2018 21:38 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 565 | $43.83 | $24,761.13 |
DisclosureSEC source: 0001127602-18-000142 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 12,541 F1 · balance_after: Includes 34 shares acquired on October 5, 2017 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2017 Filed Oct 2, 2017 20:17 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 714 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-028639 · form4.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 11,942 Read SEC document |
| September 30, 2017 Filed Oct 2, 2017 20:17 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 590 | $40.28 | $23,765.20 |
DisclosureSEC source: 0001127602-17-028639 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 11,228 F1 · balance_after: Includes 32 shares acquired on July 7, 2017 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 20:20 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 740 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-022961 · form4.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 10,606 Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 20:20 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 611 | $38.86 | $23,743.46 |
DisclosureSEC source: 0001127602-17-022961 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 9,866 F1 · balance_after: Includes 30 shares acquired on April 6, 2017 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 20:11 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 842 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-013875 · form4.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 9,225 Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 20:11 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 695 | $34.15 | $23,734.25 |
DisclosureSEC source: 0001127602-17-013875 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 8,383 F1 · balance_after: Includes 24 shares acquired on January 6, 2017 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2016 Filed Jan 3, 2017 22:03 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 890 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-000264 · form4.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 7,664 Read SEC document |
| December 31, 2016 Filed Jan 3, 2017 22:03 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 736 | $32.31 | $23,776.48 |
DisclosureSEC source: 0001127602-17-000264 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 6,774 Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 21:34 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 814 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-063719 · form4.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 6,023 Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 21:34 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 666 | $33.77 | $22,490.82 |
DisclosureSEC source: 0001127602-16-063719 · form4.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 5,209 F1 · balance_after: Includes 9 shares acquired on July 8, 2016 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 11, 2015 Filed Feb 12, 2015 21:00 UTC | STRYKER CORP SYK · Entity 369 | GrantEmployee Stock Option granted 02/11/2015 (right to buy) · Derivative | 26,865 | $0.00 Strike: $93.06 | $0.00 |
DisclosureSEC source: 0000310764-15-000019 · edgar.xml · derivative · entry 1 Jellison William R · CIK 0001189883 · VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,865 Underlying: Common Stock · 26,865 shares Expires 2025-02-10 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| February 12, 2014 Filed Feb 14, 2014 20:40 UTC | STRYKER CORP SYK · Entity 369 | GrantEmployee Stock Option granted 02/12/2014 (right to buy) · Derivative | 30,810 | $0.00 Strike: $81.14 | $0.00 |
DisclosureSEC source: 0000310764-14-000039 · edgar.xml · derivative · entry 1 Jellison William R · CIK 0001189883 · VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,810 Underlying: Common Stock · 30,810 shares Expires 2024-02-11 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| April 30, 2013 Filed May 2, 2013 20:10 UTC | STRYKER CORP SYK · Entity 369 | GrantRestricted Stock Units granted 04/30/2013 · Derivative | 15,991 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310764-13-000120 · edgar.xml · derivative · entry 2 Jellison William R · CIK 0001189883 · VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,991 Underlying: Common Stock · 15,991 shares Expires not disclosed F2 · derivative.exercise_price: Each retsricted stock unit represents a contingent right to receive one share of Stryker common stock. F2 · price: Each retsricted stock unit represents a contingent right to receive one share of Stryker common stock. F3 · derivative.exercise_date: The Restricted Stock Units vest as to 100% of the shares on April 30, 2016. Vesting will be accelerated in the event of termination of employment by reason of disability or death but will otherwise cease upon termination of employment or a significant decrease in the reporting person's role and/or responsibilities with Stryker. F3 · derivative.expiration_date: The Restricted Stock Units vest as to 100% of the shares on April 30, 2016. Vesting will be accelerated in the event of termination of employment by reason of disability or death but will otherwise cease upon termination of employment or a significant decrease in the reporting person's role and/or responsibilities with Stryker. Read SEC document |
| April 30, 2013 Filed May 2, 2013 20:10 UTC | STRYKER CORP SYK · Entity 369 | GrantEmployee Stock Option granted 04/30/2013 (right to buy) · Derivative | 63,965 | $65.66 Strike: $65.66 | $4,199,941.90 |
DisclosureSEC source: 0000310764-13-000120 · edgar.xml · derivative · entry 1 Jellison William R · CIK 0001189883 · VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,965 Underlying: Common Stock · 63,965 shares Expires 2023-04-29 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.